These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12759794)

  • 1. Prescribing information in 26 countries: a comparative study.
    Reggi V; Balocco-Mattavelli R; Bonati M; Breton I; Figueras A; Jambert E; Kopp C; Montane E; Rägo L; Rocchi F;
    Eur J Clin Pharmacol; 2003 Aug; 59(4):263-70. PubMed ID: 12759794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of prescribing information for generic drugs manufactured in the Middle East and marketed in Saudi Arabia.
    Gebran N; Al Haidari K
    Ann Saudi Med; 2006; 26(3):192-9. PubMed ID: 16861873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Information on marketed drugs for doctors and patients. Experience in six European countries.
    Brown P; Charlish P; Brazier H; Butterfield M
    Int J Technol Assess Health Care; 1995; 11(3):410-6. PubMed ID: 7591543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical information in drug package inserts in India.
    Shivkar YM
    J Postgrad Med; 2009; 55(2):104-7. PubMed ID: 19550054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient information leaflets--helpful guidance or a source of confusion?
    Bjerrum L; Foged A
    Pharmacoepidemiol Drug Saf; 2003; 12(1):55-9. PubMed ID: 12616848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of German package inserts.
    Fuchs J; Hippius M; Schaefer M
    Int J Clin Pharmacol Ther; 2006 Jan; 44(1):8-13. PubMed ID: 16425965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contraindication labelling changes in the United States and Germany.
    Garbe E; Andersohn F
    Eur J Clin Pharmacol; 2007 Jan; 63(1):87-93. PubMed ID: 17124576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Unclear on dose adjustment in renal impairment].
    Asker-Hagelberg C; Rydberg D; Hentschke M; Holm L; Rosenborg S; Elinder CG
    Lakartidningen; 2013 May 22-28; 110(21):1030-2. PubMed ID: 23805768
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of antidepressants during breastfeeding: evaluating drug package inserts conformity with science-based bibliographical sources].
    Pizzol TDSD; Moraes CG; Diello MV; Campos PM; Pletsch JT; Giugliani C
    Cad Saude Publica; 2019 Feb; 35(2):e00041018. PubMed ID: 30785486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International prescription drug labeling.
    Roylance PJ; Buri WA
    Drug Inf J; 1983; 17(4):239-43. PubMed ID: 10265098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different indications, warnings and precautions, and contraindications for the same drug--an international comparison of prescribing information for commonly used psychiatric drugs.
    Pfistermeister B; Schenk C; Kornhuber J; Bürkle T; Fromm MF; Maas R
    Pharmacoepidemiol Drug Saf; 2013 Mar; 22(3):329-33. PubMed ID: 23280570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Education responsibility, specialty and administration information from the legal viewpoint].
    Schreiber HL
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):653-7. PubMed ID: 9527463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the information "fair and balanced" in direct-to-consumer prescription drug websites?
    Huh J; Cude BJ
    J Health Commun; 2004; 9(6):529-40. PubMed ID: 15764451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Packaging of pharmaceuticals: still too many dangers but several encouraging initiatives.
    Prescrire Int; 2007 Jun; 16(89):126-8. PubMed ID: 17585428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Patient-oriented package inserts for drugs. Historical overview and current status].
    Van Haecht CH; Vander Stichele R; Bogaert M
    Arch Belg; 1989; 47(5-6):230-55. PubMed ID: 2700065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diminishing value of the Physicians' Desk Reference and drug package inserts as a medical and legal standard of medical usage of pharmaceutical drugs.
    Burkhart CG
    J Drugs Dermatol; 2005; 4(4):414-5. PubMed ID: 16004013
    [No Abstract]   [Full Text] [Related]  

  • 17. Dose discrepancies between the Physicians' Desk Reference and the medical literature, and their possible role in the high incidence of dose-related adverse drug events.
    Cohen JS
    Arch Intern Med; 2001 Apr; 161(7):957-64. PubMed ID: 11295958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The National Prescribing Service should lead.
    Stockigt JR
    Med J Aust; 2007 May; 186(9):484. PubMed ID: 17484717
    [No Abstract]   [Full Text] [Related]  

  • 19. [Written drug advertisements--are they reliable?].
    Solhaug HR; Indermo H; Slørdal L; Spigset O
    Tidsskr Nor Laegeforen; 2006 May; 126(10):1314-7. PubMed ID: 16691265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stoning a dead bird: advertising limits on approved new drugs.
    Strobos J
    Food Drug Law J; 1995; 50(4):533-51. PubMed ID: 10343018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.